Federal Marijuana Rescheduling: What Florida Defendants, Dispensaries, and Medical Patients Need to Know Now
Listen to Article
Part 1: Introduction
Overview of the DOJ rescheduling order and the false sense of safety it creates
This morning, the Justice Department issued an order moving state licensed medical marijuana and FDA approved cannabis products from Schedule I to Schedule III of the Controlled Substances Act. If you are a dispensary operator, a medical marijuana patient, a physician recommending cannabis, or someone already under federal investigation involving marijuana, this development matters. It also creates a dangerous amount of false confidence.
The order changes something important, but it does not change everything people in Florida are being told it changes. If federal agents are already looking at your conduct, or your business is preparing to move based on the headlines, you need the legal reality, not the celebration version.

The legal danger now is not misunderstanding that something changed. It is misunderstanding what stayed exactly the same.
What the Government Did and Why It Matters
Schedule I drugs carry the most restrictive federal classification. Heroin, ecstasy, and, until today, marijuana sat in that category. The practical consequence has been that marijuana research was heavily restricted, federal tax rules treated licensed dispensaries as drug traffickers, and federal prosecutors had maximum charging flexibility against anyone touching cannabis.
Schedule III includes ketamine, testosterone, and Tylenol with codeine. The designation officially recognizes that a substance has accepted medical use and lower abuse potential than Schedule I or II drugs.
The order uses two simultaneous tracks. First, it reclassifies two categories immediately: FDA approved products containing marijuana, currently Epidiolex and Marinol, and marijuana products sold under a qualifying state issued medical license. Second, it restarts the administrative rulemaking process with firm deadlines, scrapping the Biden administration's August 2024 hearing process, which the DEA concluded was moving too slowly.
President Trump signed an executive order in December 2025 directing DOJ to complete rescheduling as fast as legally possible. Today's action is the administration's attempt to do that without getting tied up in multi year administrative proceedings. Whether the legal mechanism they used survives a court challenge is a separate question.
What Changes Right Now for Dispensaries and Cannabis Businesses
The most concrete financial change is the likely end of IRS Section 280E exposure for state licensed medical marijuana operators. Section 280E has barred businesses trafficking Schedule I or II substances from deducting ordinary business expenses. A mid size dispensary operating in Florida has been paying effective federal tax rates well above 60 to 70 percent because of this provision. With marijuana moving to Schedule III, that penalty should fall away, though the IRS will need to issue formal guidance before businesses restructure their returns.
Interstate commerce remains federally illegal. Marijuana cannot lawfully cross state lines regardless of this order. State licensing and regulatory frameworks stay in place exactly as before.
If you are operating a dispensary in Florida under a state license, today's order gives you stronger ground. If you are running any operation outside that license, whether it is unlicensed grows, distribution to recreational users, or supply chains that mix licensed and unlicensed product, federal exposure is unchanged.

What Florida Medical Marijuana Patients Need to Understand
Nothing changes in Florida today. Your medical marijuana card is still required. Your physician recommendation still governs what you can obtain and use. The Florida Department of Health's regulations are not affected by this federal order. Access to medical marijuana in Florida still requires a qualifying condition and a licensed physician's recommendation, not a prescription.
One medium term change to watch is that because Schedule III classification formally acknowledges medical value, federal insurance programs including Medicare may eventually cover cannabis based therapies that receive FDA approval. That is not happening today, but the regulatory door just opened.
Patients should be especially careful about relying on social media summaries or dispensary chatter. A change in federal scheduling does not override the state level rules that control who can lawfully obtain medical marijuana in Florida and on what terms.
The Firearm Problem Did Not Go Away
This is where the order creates a genuine trap. Under 18 U.S.C. Section 922(g)(3), it is a federal crime for any unlawful user of or person addicted to a controlled substance to possess firearms or ammunition. Marijuana remains a controlled substance under this order. Schedule III drugs are still controlled substances. The ATF Form 4473 that every federally licensed dealer requires still asks whether you are an unlawful user of any controlled substance.
Several federal circuit courts are currently litigating whether the marijuana user gun prohibition violates the Second Amendment under the Supreme Court's Bruen framework. The outcomes are genuinely uncertain. But the current law is enforceable right now. A Florida medical marijuana cardholder who purchases or possesses firearms is still at federal risk, and today's rescheduling action does not change that analysis.

The most dangerous assumption after today's order is that gun possession and marijuana use no longer conflict under federal law. They still do.
The Charges That Have Not Gone Away
Federal prosecutors retain full authority to pursue marijuana trafficking, distribution, and conspiracy charges under 21 U.S.C. Section 841. The order protects state licensed medical programs. It does nothing for unlicensed cultivation, black market distribution, or any conduct outside a qualifying state license.
The federal sentencing consequences for marijuana trafficking remain severe. Under the Sentencing Guidelines, drug quantity drives the offense level. Large scale trafficking operations face guideline ranges of 10 years to life, and prosecutors add conspiracy charges under 21 U.S.C. Section 846 that carry identical penalties. The rescheduling order has no effect on pending federal indictments or the sentencing calculations that apply to them.
One thing the headlines are not covering is that the DOJ internally rescinded its policy of non prosecution for marijuana possession in 2025, directing U.S. Attorneys to pursue charges more aggressively. That enforcement posture was not softened by today's announcement.

Critical Mistakes People Make After a Policy Change Like This
Major policy announcements create a false sense of security. People assume that because marijuana is being rescheduled, federal risk has dropped everywhere. That assumption is wrong, and acting on it without counsel can be costly.
Here are the most common mistakes in the weeks following a development like today's order:
- Expanding operations before the legal situation stabilizes. The order is already facing a legal challenge from Smart Approaches to Marijuana, which retained former Attorney General Bill Barr to sue immediately. If a court enjoins the order, any business that expanded in reliance on it is in a precarious position.
- Assuming pending federal charges will be dropped or reduced. They will not. Federal prosecutors with open cases will not unilaterally dismiss based on a policy change that does not affect the underlying statutes or pending indictments.
- Talking to DEA or FBI agents without counsel, under the assumption that the legal climate has shifted in your favor. It has not shifted enough to make that conversation safe.
- Structuring new transactions without advice on how the IRS will actually treat Schedule III operators before formal guidance is issued. Acting on assumptions about 280E before the IRS weighs in is a mistake.
- Ignoring the firearm issue. Florida's concealed carry laws and broad gun ownership mean this catches more people than it appears. If you hold a medical marijuana card and own firearms, that combination requires a careful legal review before the situation creates a federal problem.
How Defense Strategy Changes Right Now
If you are under federal investigation involving marijuana, today's order is relevant to your case but it is not a get out of jail card. It shifts the prosecutorial posture on licensed medical conduct. That shift is real, and it is worth understanding before your next conversation with law enforcement or your next court appearance.
Early intervention changes what is possible in federal cannabis cases. The window between when a grand jury opens and when an indictment is returned is where a federal criminal defense attorney can actually move the needle. That window includes proffer discussions, cooperation evaluations, and direct contact with the assigned AUSA to understand the scope and direction of the investigation. Once charges are filed, those conversations happen on the government's terms, not yours.
For dispensary operators who receive a federal subpoena or learn they are the target of a DEA investigation, the immediate priority is understanding what conduct the government is focused on. Is it licensing compliance, financial flows, or an employee's conduct. The answer shapes whether cooperation is viable, what documents need to be preserved, and whether the civil regulatory track and the criminal track are diverging.
For individuals facing marijuana charges, the rescheduling creates new sentencing arguments. The government's own acknowledgment that marijuana has accepted medical use and lower abuse potential is now in the Federal Register. Sentencing courts weigh 18 U.S.C. Section 3553(a) factors, including the kinds of sentences available for defendants with similar conduct. A sentencing memorandum in a marijuana case filed after today can make arguments that were not available last week.
Why Timing Still Matters
Charging decisions in federal investigations are not final until an indictment is returned. Before that point, a federal criminal defense attorney can sometimes affect what charges are brought, whether charges are brought at all, and how the government frames the case. That is not a guarantee, and it does not happen in every case. But it cannot happen at all if you wait.
The period immediately following a major policy change is when federal enforcement priorities are being recalibrated. Right now, there is genuine ambiguity about how U.S. Attorneys' offices will treat the line between licensed and unlicensed conduct now that rescheduling is official. That ambiguity is not your friend if you are unrepresented. It is an opening if you have counsel who can engage the relevant AUSA while the government is still working through its own posture.
For licensed dispensary operators, today's order strengthens your legal position in ongoing regulatory proceedings. The argument that your conduct falls within federally recognized medical marijuana activity is on firmer ground now than it was 24 hours ago.
Contact AMC Defense Law
AMC Defense Law handles federal and state criminal matters throughout Florida, including federal drug investigations, cannabis trafficking, firearms charges, and white collar cases with regulatory overlap. Our attorneys have handled complex federal cases from investigation through sentencing, with results that include dismissed charges, reduced sentences, and acquittals.
If you are under investigation, have been contacted by federal agents, or are operating in the cannabis space and have questions about how today's order affects your exposure, the time to have that conversation is before the situation escalates.

When federal policy changes, the risk is rarely in the headline. It is in what investigators, prosecutors, and regulators do next.
If you or your loved ones have been arrested or are under investigation, call Aaron M. Cohen, 24 hours a day to get help.
DISCLAIMER: This article is provided for informational purposes only and does not constitute legal advice or create an attorney client relationship. Criminal law and federal regulations change frequently. The information above reflects developments as of April 23, 2026, and may not account for subsequent legal or regulatory changes. If you have a specific legal situation, consult a licensed criminal defense attorney promptly.
Listen to Article
Part 1: Introduction
Overview of the DOJ rescheduling order and the false sense of safety it creates

Aaron M. Cohen
Principal Attorney
Aaron M. Cohen is a nationally recognized criminal defense attorney with over 30 years of experience representing individuals and entities in complex criminal investigations and prosecutions across the United States.
View Attorney Profile